Catalysts for Actemra
61 tracked
Apr 30, 2026
phase 1 completion
Chugai Pharmaceutical Co Ltd โ tocilizumab (Phase I Trial Completion)
tocilizumab
โ
Dec 10, 2025
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 10, 2025
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Aug 8, 2025
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Aug 8, 2025
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 10, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 10, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Sep 20, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Sep 20, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Sep 19, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Sep 19, 2024
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 21, 2022
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 21, 2022
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Feb 28, 2022
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Feb 28, 2022
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Oct 22, 2021
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Oct 22, 2021
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Mar 4, 2021
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Mar 4, 2021
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) โ FDA approval
tocilizumab
โ